UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Measurement of CYP1A2 activity: a focus on caffeine as a probe

Current drug metabolism, 2012-06, Vol.13 (5), p.667-678

2012

Volltextzugriff (PDF)

Insights into dasatinib use and outcomes in real-world patients with chronic myeloid leukemia

Haematologica (Roma), 2023-08, Vol.108 (8), p.2224-2228

2023

Volltextzugriff (PDF)

The Extent and Impact of Variation in ADME Genes in Sub-Saharan African Populations

Frontiers in pharmacology, 2021-04, Vol.12, p.634016

2021

Volltextzugriff (PDF)

Application of physiologically based pharmacokinetic modeling to understand real‐world outcomes in patients receiving imatinib for chronic myeloid leukemia

Pharmacology research & perspectives, 2023-08, Vol.11 (4), p.e01082-n/a

2023

Volltextzugriff (PDF)

Real‐world efficacy and safety outcomes of imatinib treatment in patients with chronic myeloid leukemia: An Australian experience

Pharmacology research & perspectives, 2022-10, Vol.10 (5), p.n/a

2022

Volltextzugriff (PDF)

A physiologically based pharmacokinetic model of clopidogrel in populations of European and Japanese ancestry: An evaluation of CYP2C19 activity

Pharmacology research & perspectives, 2022-04, Vol.10 (2), p.e00946-n/a

2022

Volltextzugriff (PDF)

Single and Multiple Dose Pharmacokinetics, Pharmacodynamics and Safety of the Novel Lipoprotein-Associated Phospholipase A2 Enzyme Inhibitor Darapladib in Healthy Chinese Subjects: An Open Label Phase-1 Clinical Trial

PloS one, 2015-10, Vol.10 (10), p.e0139862-e0139862

2015

Volltextzugriff (PDF)

Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasma

Biomedical chromatography, 2010-10, Vol.24 (10), p.1136-1144

2010

Volltextzugriff (PDF)

Clinical trial diversity: An opportunity for improved insight into the determinants of variability in drug response

British journal of clinical pharmacology, 2022-06, Vol.88 (6), p.2700-2717

2022

Volltextzugriff (PDF)

HPLC assay for bupropion and its major metabolites in human plasma

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005-09, Vol.823 (2), p.115-121

2005

Volltextzugriff (PDF)

Oral Sulfasalazine as a Clinical BCRP Probe Substrate: Pharmacokinetic Effects of Genetic Variation (C421A) and Pantoprazole Coadministration

Journal of pharmaceutical sciences, 2010-02, Vol.99 (2), p.1046-1062

2010

Volltextzugriff (PDF)

The Effects of Cruciferous Vegetable‐Enriched Diets on Drug Metabolism: A Systematic Review and Meta‐Analysis of Dietary Intervention Trials in Humans

Clinical pharmacology and therapeutics, 2020-08, Vol.108 (2), p.212-227

2020

Volltextzugriff (PDF)

Physiologically‐based pharmacokinetic model predictions of inter‐ethnic differences in imatinib pharmacokinetics and dosing regimens

British journal of clinical pharmacology, 2022-02, Vol.88 (4), p.1735-1750

2022

Volltextzugriff (PDF)

Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

BMC pulmonary medicine, 2015-12, Vol.15 (159), p.165-165, Article 165

2015

Volltextzugriff (PDF)

An improved cytochrome P450 phenotyping cocktail with a simplified and highly sensitive UHPLC-MS/MS assay in human plasma

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2020-03, Vol.1140, p.122013-122013, Article 122013

2020

Volltextzugriff (PDF)

Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics

Journal of pharmacy and pharmacology, 2011-09, Vol.63 (9), p.1161-1168

2011

Volltextzugriff (PDF)

Best practice in therapeutic drug monitoring

British journal of clinical pharmacology, 1998-08, Vol.46 (2), p.95-99

Gross, Annette S.

1998

Volltextzugriff (PDF)

Characterization of ADME gene variation in 21 populations by exome sequencing

Pharmacogenetics and genomics, 2017-03, Vol.27 (3), p.89-100

2017

Volltextzugriff (PDF)

Stereoselective analysis of hydroxybupropion and application to drug interaction studies

Chirality (New York, N.Y.), 2007-03, Vol.19 (3), p.163-170

2007

Volltextzugriff (PDF)

The role of ethnicity in personalized dosing of small molecule tyrosine kinase inhibitors used in oncology

Translational cancer research, 2017-12, Vol.6 (S10), p.S1558-S1591

2017

Volltextzugriff (PDF)

Risk factors for breast cancer in East Asian women relative to women in the West

Asia-Pacific journal of clinical oncology, 2009-12, Vol.5 (4), p.219-231

2009

Volltextzugriff (PDF)

Comparison of the Pharmacokinetics of RIPK1 Inhibitor GSK2982772 in Healthy Western and Japanese Subjects

European journal of drug metabolism and pharmacokinetics, 2021-01, Vol.46 (1), p.71-83

2021

Volltextzugriff (PDF)

Pharmacokinetic, Safety, and Tolerability Evaluations of Gepotidacin (GSK2140944) in Healthy Japanese Participants

Clinical pharmacology in drug development, 2023-01, Vol.12 (1), p.38-56

2023

Volltextzugriff (PDF)

Diurnal variation in CYP1A2 enzyme activity in South Asians and Europeans

Journal of pharmacy and pharmacology, 2013-02, Vol.65 (2), p.264-270

2013

Volltextzugriff (PDF)

Evaluation of the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Pyrimethamine in Healthy Male Subjects of Japanese and European Ancestry

Clinical pharmacology in drug development, 2020-08, Vol.9 (6), p.768-773

2020

Volltextzugriff (PDF)

1 – 25 von 264

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(237)
Mit Volltextzugriff
(219)

Publikationsform

Sprache

Englisch
(260)
Japanisch
(34)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Measurement of CYP1A2 activity: a focus on caffeine as a probe

Insights into dasatinib use and outcomes in real-world patients with chronic myeloid leukemia

The Extent and Impact of Variation in ADME Genes in Sub-Saharan African Populations

Application of physiologically based pharmacokinetic modeling to understand real‐world outcomes in patients receiving imatinib for chronic myeloid leukemia

Real‐world efficacy and safety outcomes of imatinib treatment in patients with chronic myeloid leukemia: An Australian experience

A physiologically based pharmacokinetic model of clopidogrel in populations of European and Japanese ancestry: An evaluation of CYP2C19 activity

Single and Multiple Dose Pharmacokinetics, Pharmacodynamics and Safety of the Novel Lipoprotein-Associated Phospholipase A2 Enzyme Inhibitor Darapladib in Healthy Chinese Subjects: An Open Label Phase-1 Clinical Trial

Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasma

Clinical trial diversity: An opportunity for improved insight into the determinants of variability in drug response

HPLC assay for bupropion and its major metabolites in human plasma

Oral Sulfasalazine as a Clinical BCRP Probe Substrate: Pharmacokinetic Effects of Genetic Variation (C421A) and Pantoprazole Coadministration

The Effects of Cruciferous Vegetable‐Enriched Diets on Drug Metabolism: A Systematic Review and Meta‐Analysis of Dietary Intervention Trials in Humans

Physiologically‐based pharmacokinetic model predictions of inter‐ethnic differences in imatinib pharmacokinetics and dosing regimens

Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

An improved cytochrome P450 phenotyping cocktail with a simplified and highly sensitive UHPLC-MS/MS assay in human plasma

Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics

Best practice in therapeutic drug monitoring

Characterization of ADME gene variation in 21 populations by exome sequencing

Stereoselective analysis of hydroxybupropion and application to drug interaction studies

The role of ethnicity in personalized dosing of small molecule tyrosine kinase inhibitors used in oncology

Risk factors for breast cancer in East Asian women relative to women in the West

Comparison of the Pharmacokinetics of RIPK1 Inhibitor GSK2982772 in Healthy Western and Japanese Subjects

Pharmacokinetic, Safety, and Tolerability Evaluations of Gepotidacin (GSK2140944) in Healthy Japanese Participants

Diurnal variation in CYP1A2 enzyme activity in South Asians and Europeans

Evaluation of the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Pyrimethamine in Healthy Male Subjects of Japanese and European Ancestry

Suchergebnisse filtern